| behçet’s disease |
511, 558, 607 |
| behçet’s syndrome |
511 |
| tnf inhibitors |
511 |
| treatment |
511 |
| treat-to-target |
511 |
| abdominal pain |
522 |
| fecal calprotectin |
522 |
| fibromyalgia syndrome |
522 |
| irritable bowel syndrome |
522 |
| chondrocytes |
529 |
| linc00472 |
529 |
| mir-361-5p |
529 |
| mecp2 |
529 |
| osteoarthritis |
529, 641 |
| antinuclear antibody |
541 |
| autoantibody |
541 |
| covid-19 |
541 |
| indirect fluorescent antibody test |
541 |
| sars cov-2 |
541 |
| coronary artery aneurysms |
549 |
| health-related quality of life |
549 |
| kawasaki disease |
549 |
| pediatric quality of life inventory |
549 |
| etdq-7 questionnaire |
558 |
| eustachian tube function test |
558 |
| eustachian tube |
558 |
| clinical practice review |
566 |
| deficiency of interleukin-1 receptor antagonist |
566 |
| epidemiology |
566 |
| interleukin-1 |
566 |
| arthritis |
579 |
| rheumatoid |
579 |
| semi-quantitative scoring |
579 |
| seronegative |
579 |
| ultrasonic |
579 |
| autoimmunity |
588 |
| cytopenia |
588 |
| immunodeficiency |
588 |
| rheumatic disease |
588 |
| splenomegaly |
588 |
| adaptive immunity |
598 |
| interferon-gamma |
598 |
| interleukin-17 |
598 |
| takayasu arteritis |
598 |
| t helper 17 cells |
598 |
| behçet’s syndrome overall damage index |
607 |
| damage assessment |
607 |
| outcome assessment |
607 |
| validation |
607 |
| rheumatoid arthritis |
617 |
| small joints of the hands |
617 |
| thermal imaging |
617 |
| behçet's disease |
624 |
| diastolic dysfunction |
624 |
| vasculitis |
624 |
| interstitial lung disease |
631 |
| psoriatic arthritis |
631 |
| pulmonary ınvolvement |
631 |
| arch height index |
641 |
| arch stiffness |
641 |
| knee |
641 |
| medial longitudinal arch |
641 |
| ankylosing spondylitis |
652 |
| carotid intima-media thickness |
652 |
| proprotein convertase subtilisin/kexin type 9 |
652 |
| subclinical atherosclerosis |
652 |
| disease-modifying antirheumatic drugs |
662 |
| juvenile idiopathic arthritis |
662 |
| pediatric rheumatology |
662 |
| transition |
662 |
| children |
670 |
| immunoglobulin a vasculitis |
670 |
| thrombophilia |
670 |
| thrombosis |
670 |
